Introduction of New Vaccine will stimulate US Cancer Vaccine Market

According to a new research report by RNCOS entitled, ?US Cancer Vaccine Market Outlook 2020?, US cancer vaccine industry has been slow growth in overall vaccine market, in 2014, US Cancer Vaccine market generated approximately US$ 4.32 Billion revenue and CAGR of 1.4% is expected during the period 2014-2020, backed by the factors such as introduction of new vaccine in clinical trials, increasing awareness, increasing investment by public and private players and intense competition.

Currently, more than 20% of the therapeutic cancer vaccines in phase-3 clinical trials are for the treatment of lung cancer. This is reflective of the high demand that exists owing to the high incidence and prevalence of lung cancer in US. But for other leading cancer namely cancer of the prostate, breast, colon & rectum and corpus & uterus, NOS; there are few vaccine candidates in advanced phases of clinical trials. The most neglected segment is of the cancer of corpus & uterus, NOS (endometrial cancer) where no candidate exists in phase-3 clinical trial.

Regarding competitive landscape scenario, Merck & Co. holds a largest share in the US cancer vaccine market. Gardasil has established the company as one of the leading names in vaccine industry. Players such as Galena Biopharma, GSK, Celldex Therapeutics, Kael- Gemvax and Bavarian Nordic hold important place in the market and their future strategies will define the shifts in market dynamics. These companies are focusing on identifying new targets for cancer vaccines that can be extended to multiple cancer types and are conducting trials robustly across different population segments.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM772.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.

Company :-RNCOS E-Services Pvt. Ltd.

User :- Shushmul Maheshwari

Email :-press@rncos.com

Phone :-91-120-4224700

Mobile:- -

Url :- http://www.rncos.com